Pharma Focus Europe

Dandelion Science and the Wyss Center in Geneva Launch AI Partnership to Innovate Non-Invasive Brain Therapies

Wednesday, June 12, 2024

The Wyss Center for Bio and Neuroengineering in Geneva and Dandelion Science have announced a partnership to develop a cutting-edge generative AI neuromodulation platform. This collaboration aims to advance non-invasive treatments for neurodegenerative and neuropsychiatric disorders by utilizing generative artificial intelligence to create customized sensory stimulation therapies.

Wyss Center, expressed his excitement about the partnership, noting, "We are thrilled to collaborate with Dandelion Science. The potential of generative AI to transform brain disorder treatments is exciting. Our focus on AI-guided neuromodulation aims to develop smarter therapies for neurological and mental health conditions by combining artificial intelligence with innovative non-invasive neuromodulation techniques targeting deep brain structures. Dandelion's groundbreaking technology, strong intellectual property, and skilled team make them an ideal partner. We look forward to the significant impact this technology could have on patients worldwide."

This collaboration leverages the extensive resources and clinical expertise of the Wyss Center, providing Dandelion Science with access to a variety of clinical partners, and integrating them into a broader ecosystem of AI and neurotechnology over the next four years.

Dandelion Science and newly appointed Expert-in-Residence at the Wyss Center in Geneva, said, "Generative neuromodulation is set to become a major industry. Dandelion's advanced computational methods, which mimic how the brain processes information, promise to create therapies that directly address complex dysfunctions. We chose to work with the Wyss Center to pioneer ethical approaches in this revolutionary field. This partnership not only validates Dandelion's work but also significantly enhances our capacity for innovation and impact."

 

Source: prnewswire.com

magazine-slider-img
Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024
cytiva